• Advertise
  • Contact Us
  • Daily The Business
  • Privacy Policy
Social icon element need JNews Essential plugin to be activated.
Thursday, May 21, 2026
Daily The Business
  • Login
No Result
View All Result
DTB
No Result
View All Result
DTB

India flags quality issues with some widely used antacids and paracetamol

September 27, 2024
in World
India flags quality issues with some widely used antacids and paracetamol

BENGALURU: India’s drug regulator has found more than 50 drugs, including some batches of widely used antacids and paracetamol, to be substandard or fake, according to government documents.

The regulator, Central Drugs Standard Control Organisation, releases a monthly list of substandard or fake medicines sold in the country after routine tests across the country by multiple agencies.

The regulator found some drugs as “not of standard quality”, including a batch each of Alkem Laboratories’ popular antacid Pan-D, Hetero’s anti-infective Cepodem and Shelcal, a vitamin and calcium tablet brand made by privately-owned Pure & Cure Healthcare, and several antibiotics, according to the lists for August.

Sun Pharmaceutical Industries separately informed the regulator of a fake batch of Pantocid, a popular Indian brand of an antacid called pantoprazole. The agency said it is investigating the matter. Fake, or “spurious”, batches of Sun’s drug Pulmosil, used to treat high blood pressure in the lungs, and Glenmark Pharmaceuticals’ anti-hypertension drug Telma H, among others, were also notified by the companies to the regulator and were being investigated.

“When a medicine is found to be below quality standards, the drug regulator sends a notice to the manufacturer to check and recall that batch of product. Companies too conduct their own tests on leftover samples to check for the possibility of counterfeit,” said Rajiv Singhal, general secretary of drug retailer body All India Organisation of Chemists and Druggists.

Pharma industry: Govt reaffirms pledge to provide conducive environment

The companies did not immediately respond to Reuters’ request for comment. Gastrointestinal, anti-diabetic, vitamins and nutraceutical drug sales were one of the top contributors to the domestic pharma market growth in August, according to research firm Pharmarack.

India, one of the world’s largest drug producers and exporters, is working to restore confidence after Indian-made cough syrups were linked to the deaths of children in Gambia, Uzbekistan, and Cameroon.

Tags: All India Organisation of Chemists and DruggistsantacidsIndiaIndia drug regulatorparacetamol
Previous Post

Israel rejects US-backed Lebanon ceasefire plan, hits Beirut again

Next Post

What obstacles stand in the way of an Israel-Hezbollah cease-fire?

American Dollar Exchange Rate
Write us: info@dailythebusiness.com

© 2021 Daily The Business

Social icon element need JNews Essential plugin to be activated.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result

© 2021 Daily The Business

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Premium SEO Backlinks
Hacklink Satın Al
Premium SEO Backlinks